Camino Fidalgo Selected Research

eltoprazine

4/2016	Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
2/2016	Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Camino Fidalgo Research Topics

Disease

7	Dyskinesias (Dyskinesia) 11/2017 - 12/2013
5	Parkinson Disease (Parkinson's Disease) 01/2017 - 12/2013
2	Hepatic Encephalopathy 01/2021 - 03/2014
2	Portal Hypertension 05/2014 - 01/2013
1	Cognitive Dysfunction 01/2021
1	Memory Disorders (Memory Loss) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Hyperammonemia 03/2014

Drug/Important Bio-Agent (IBA)

7	Levodopa (L Dopa)FDA LinkGeneric 11/2017 - 12/2013
4	Dopamine (Intropin)FDA LinkGeneric 11/2017 - 12/2013
3	Serotonin (5 Hydroxytryptamine)IBA 11/2017 - 12/2013
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 05/2014
2	eltoprazineIBA 04/2016 - 02/2016
2	AmmoniaIBA 03/2014 - 01/2013
1	phytobacteriomycin (PBM)IBA 01/2021
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2021
1	EnzymesIBA 01/2021
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2017
1	BenserazideIBA 11/2017
1	Nerve Growth Factors (Neurotrophins)IBA 11/2017
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2017
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2017
1	Finasteride (Propecia)FDA LinkGeneric 01/2017
1	SK&F 82958 (SKF 82958)IBA 01/2017
1	5-alpha Reductase InhibitorsIBA 01/2017
1	ropinirole (Requip)FDA LinkGeneric 01/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2016
1	LigandsIBA 04/2016
1	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 04/2016
1	Therapeutic UsesIBA 04/2016
1	Amphetamine (Amfetamine)FDA LinkGeneric 02/2014
1	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 12/2013
1	Thioacetamide (Thioacetamid)IBA 01/2013

Therapy/Procedure

2	Therapeutics 02/2016 - 01/2015
2	Cell Transplantation 01/2015 - 02/2014
1	Low-Level Light Therapy (LLLT) 01/2021
1	Transplantation 01/2015